-
Loading metrics
A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age
- Alphonse Ouédraogo,
- Alfred B. Tiono,
- Désiré Kargougou,
- Jean Baptiste Yaro,
- Esperance Ouédraogo,
- Youssouf Kaboré,
- David Kangoye,
- Edith C. Bougouma,
- Adama Gansane,
- Noelie Henri
x
- Published: November 11, 2013
- https://doi.org/10.1371/journal.pone.0078679